Identification of a long noncoding RNA signature to predict outcomes of glioblastoma

De‐Pei Li(University of Missouri Health System), Lei Yu(Taiyuan Central Hospital), Songtao Qi(Nanfang Hospital), Hong Li(Nanfang Hospital), Jie Lu(Shandong Provincial Hospital)
Molecular Medicine Reports
April 24, 2019
10.3892/mmr.2019.10184
Cited by 26

Related Papers

Plasma MicroRNA Panel to Diagnose Hepatitis B Virus–Related Hepatocellular Carcinoma
|Journal of Clinical Oncology|2011|644
Adjuvant Transarterial Chemoembolization for HBV-Related Hepatocellular Carcinoma After Resection: A Randomized Controlled Study
|Clinical Cancer Research|2018|355
<i>IDH</i> mutations predict longer survival and response to temozolomide in secondary glioblastoma
|Cancer Science|2011|296
Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma
|Molecular Cancer|2014|228
Acquired temozolomide resistance in MGMT-deficient glioblastoma cells is associated with regulation of DNA repair by DHC2
|Brain|2019|186